Examining the role of oxytocin in the interoceptive effects of 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) using a drug discrimination paradigm in the rat
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
3,4‐Methylenedioxymethamphetamine (MDMA, ‘ecstasy’) use results in distinctive mood changes of a prosocial nature, most likely through its enhancement of serotonin (5HT) neurotransmission. Activation of 5HT‐1A postsynaptic receptors has been shown to stimulate the release of oxytocin in the central nervous system where it regulates aspects of mood and behavior. Using a drug discrimination paradigm, we examined whether modulation of oxytocin receptor activity would affect conditioned behavioral responses to MDMA. Male and female Sprague Dawley rats (n = 24) were trained to reliably differentiate between MDMA and a related stimulant, amphetamine (AMP), and saline using a three‐lever drug discrimination paradigm. The extent to which substitution with carbetocin (an oxytocin analog) or co‐administration with atosiban (an oxytocin receptor antagonist) affected drug‐appropriate responding was evaluated. The tricyclic antidepressant imipramine was included as a negative control. The results supported the hypotheses that substitution with an oxytocin analog (carbetocin) would partially generalize to the MDMA training cue, whereas blocking oxytocin receptors with atosiban would result in a selective disruption of MDMA––but not AMP‐appropriate responding. These findings were specific to the oxytocin receptor ligands as imipramine pre‐treatment did not affect drug‐appropriate responding. The results of this study implicate oxytocin receptor activation as a key MDMA‐specific interoceptive cue in male and female rats and support the conclusion that this is one of the features of MDMA's subjective effects that distinguishes it from AMP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heinrichs, M., Baumgartner, T., Kirschbaum, C., & Ehlert, U. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00465-7 · Cited by 2,091 · cited 2×
“Recent studies examining the effects of exogenous oxytocin on mood and social cognition in humans have reported oxytocin to have positive modulatory effects on stress (Heinrichs et al. 2003) and trust (Kosfeld et al.”
BackgroundThe Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
Green, A. R., Mechan, A. O., Elliott, J. M., O’Shea, E., & Colado, M. I. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.3 · Cited by 1,272
Landgraf, R., & Neumann, I. D. (2004) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2004.05.001 · Cited by 1,059
Vasopressin and Oxytocin Excite Distinct Neuronal Populations in the Central Amygdala
Huber, D., Veinante, P., & Stoop, R. (2005) · Science · doi:10.1126/science.1105636 · Cited by 804
Oxytocin attenuates amygdala responses to emotional faces regardless of valence
Domes, G., Heinrichs, M., Gläscher, J., Büchel, C., Braus, D. F., & Herpertz, S. C. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.025 · Cited by 774 · cited 2×
“…on mood and social cognition in humans have reported oxytocin to have positive modulatory effects on stress (Heinrichs et al. 2003) and trust (Kosfeld et al. 2005) and to enhance interpretation of facial expressions in normal (Domes et al. 2007) and clinical populations (Hollander et al. 2007).”
BackgroundOxytocin Increases Retention of Social Cognition in Autism
Hollander, E., Bartz, J., Chaplin, W., Phillips, A., Sumner, J., Soorya, L., Anagnostou, E., & Wasserman, S. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.030 · Cited by 693 · cited 1×
“…on mood and social cognition in humans have reported oxytocin to have positive modulatory effects on stress (Heinrichs et al. 2003) and trust (Kosfeld et al. 2005) and to enhance interpretation of facial expressions in normal (Domes et al. 2007) and clinical populations (Hollander et al. 2007).”
BackgroundNeuropeptidergic regulation of affiliative behavior and social bonding in animals
Lim, M. M., & Young, L. J. (2006) · Hormones and Behavior · doi:10.1016/j.yhbeh.2006.06.028 · Cited by 624
Thompson, M. R., Callaghan, P. D., Hunt, G. E., Cornish, J. L., & McGregor, I. S. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.02.032 · Cited by 237 · cited 7×
“In vitro and in vivo evidence from both human and animal studies shows that MDMA also triggers the release of oxytocin into plasma (Wolff et al. 2006; Thompson et al. 2007), which in rats has been shown to be dependent on the activation of postsynaptic serotonergic receptors (Thompson et al. 2007).”
BackgroundInfluentialCamí, J., Farré, M., Mas, M., Roset, P. N., Poudevida, S., Mas, A., San, L., & de la Torre, R. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200008000-00010 · Cited by 234 · cited 1×
“For example, discriminable effects have been reported in humans following doses of 1–2 mg/kg orally (75 and 125 mg; Camí et al. 2000).”
BackgroundA review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers
Dumont, G. J. H., & Verkes, R. J. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106063271 · Cited by 149 · cited 1×
“…may underpin the increase in social interaction that is a hallmark characteristic of MDMA’s effects in rats (Thompson et al. 2007) and in humans (Dumont & Verkes 2006) provides a clear indication that oxytocin is likely to contribute to the subjective effects experienced in the context of MDMA…”
Background
Cited by
Breaking the loop: Oxytocin as a potential treatment for drug addiction
McGregor, I. S., & Bowen, M. T. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.12.001 · Cited by 268
“A role for oxytocin in the subjective effects of MDMA is further underlined by findings that the oxytocin antagonist atosiban interferes with MDMA, but not amphetamine, appropriate responding in rats trained to discriminate these drugs from placebo (Broadbear et al., 2011).”
BackgroundMacDonald, K., & Feifel, D. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00035 · Cited by 181
MDMA enhances “mind reading” of positive emotions and impairs “mind reading” of negative emotions
Hysek, C. M., Domes, G., & Liechti, M. E. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2645-9 · Cited by 144
Zanos, P., Georgiou, P., Wright, S. R., Hourani, S. M., Kitchen, I., Winsky-Sommerer, R., & Bailey, A. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.285 · Cited by 133
“4 There is emerging evidence supporting the involvement of OT in the effects of a number of drugs of abuse and in preventing relapse to drug-seeking (Broadbear et al, 2011; McGregor and Bowen, 2012; McGregor et al, 2008; Sarnyai, 2011).”
BackgroundRamos, L., Hicks, C., Kevin, R., Caminer, A., Narlawar, R., Kassiou, M., & McGregor, I. S. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.125 · Cited by 128
Metadata
- Authors
- Broadbear, J. H., Tunstall, B., & Beringer, K.
- Venue
- Addiction Biology
- Publisher
- Wiley
- Published
- 2010-11-11
- Volume
- 16
- Issue
- 2
- Pages
- 202-214
- ISSN
- 1355-6215 (ISSN-L)
- 1369-1600
- OpenAlex
- W1903518157
- Cited by
- 38
- References
- 13
- FWCI
- 5.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Examining the role of oxytocin in the interoceptive effects of 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) using a drug discrimination paradigm in the rat. https://app.cochat.ai/papers/10.1111/j.1369-1600.2010.00267.x
- The paper
- Broadbear, J. H., Tunstall, B., & Beringer, K. (2011). Examining the role of oxytocin in the interoceptive effects of 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) using a drug discrimination paradigm in the rat. Addiction Biology. https://doi.org/10.1111/j.1369-1600.2010.00267.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.